Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

• 主要な著者: Christer F. Aas (著者), Jørn Henrik Vold (著者), Svetlana Skurtveit (著者), Ingvild Odsbu (著者), Fatemeh Chalabianloo (著者), Aaron G. Lim (著者), Kjell Arne Johansson (著者), Lars Thore Fadnes (著者)
• フォーマット: 図書
• 出版事項: BMC, 2020-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) programs. The objective of this study was to estimate and to compare HC...